Vaccination and Eradication:

We can consider modify the virulent factor and used it as a vaccine. As we know that, when Mycoplasma pneumonia is interacted with the host cells, it will inhibit the host cells’ catalase which can be used to breaks down hydrogen peroxide and toxic form of oxygen which is lethal to the cells. We can introduce anti-toxin as a vaccine which is to be injected to the human for prevention of the disease.

Gene-modified Mycoplasma pneumoniae can be considered to be made into vaccine against itself too. The gene therapy required method eliminates the disease-causing gene and replaced it with a modified gene, which can be inserted with functions that enhance the cell regulatory in host cells. Little amount of the gene-modified M. pneumonia can be injected to human body as a vaccine and trigger the immune response of the human body to produce antibody of immune cells to bind at the surface protein of the pathogens and attract phagocytes to kill them.